BIONTECH SE

NASDAQ: BNTX (BioNTech SE)

最近更新时间: 13小时之前

113.04

-0.48 (-0.43%)

前收盘价格 113.52
收盘价格 114.08
成交量 151,954
平均成交量 (3个月) 856,351
市值 27,173,502,976
预期市盈率 (P/E Forward) 7.04
价格/销量 (P/S) 8.10
股市价格/股市净资产 (P/B) 1.26
52周波幅
81.20 (-28%) — 131.49 (16%)
利润日期 3 Nov 2025
营业毛利率 -27.89%
营业利益率 (TTM) -270.46%
稀释每股收益 (EPS TTM) -3.72
季度收入增长率 (YOY) -2.60%
季度盈利增长率 (YOY) -43.30%
总债务/股东权益 (D/E MRQ) 1.55%
流动比率 (MRQ) 10.18
营业现金流 (OCF TTM) -255.70 M
杠杆自由现金流 (LFCF TTM) -335.98 M
资产报酬率 (ROA TTM) -3.67%
股东权益报酬率 (ROE TTM) -3.94%

市场趋势

短期 中期
行业 Biotechnology (US) 混合的 看跌
Biotechnology (全球的) 混合的 看跌
股票 BioNTech SE 混合的 看跌

AIStockmoo 评分

1.1
分析师共识 0.5
内部交易活动 NA
价格波动 2.0
技术平均移动指标 0.0
技术振荡指标 2.0
平均 1.13

相关股票

股票 市值 DY P/E(TTM) P/B
BNTX 27 B - - 1.26
MTSR 3 B - - 7.22
GPCR 1 B - - 1.43
ORKA 572 M - - -
MBX 444 M - - 1.72
JBIO 241 M - - -

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

部门 Healthcare
行业 Biotechnology
内部持股比例 62.69%
机构持股比例 22.24%
52周波幅
81.20 (-28%) — 131.49 (16%)
目标价格波幅
110.00 (-2%) — 155.00 (37%)
155.00 (Truist Securities, 37.13%) 购买
134.00 (18.55%)
110.00 (Goldman Sachs, -2.69%) 保留
平均值 133.43 (18.04%)
总计 5 购买, 2 保留
平均价格@调整类型 109.10
公司 日期 目标价格 调整类型 价格@调整类型
HC Wainwright & Co. 14 Aug 2025 136.00 (20.32%) 购买 112.70
25 Jun 2025 138.00 (22.09%) 购买 104.80
B of A Securities 05 Aug 2025 134.00 (18.55%) 购买 111.07
16 Jul 2025 126.00 (11.47%) 购买 112.49
Wells Fargo 05 Aug 2025 150.00 (32.70%) 购买 111.07
Morgan Stanley 10 Jul 2025 133.00 (17.66%) 购买 113.92
Truist Securities 03 Jun 2025 155.00 (37.13%) 购买 115.64
Goldman Sachs 29 May 2025 110.00 (-2.69%) 保留 100.25
JP Morgan 22 May 2025 116.00 (2.62%) 保留 99.07

该时间范围内无数据。

日期 类型 细节
04 Aug 2025 公告 BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
04 Aug 2025 公告 BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update
31 Jul 2025 CNBC Pandemic darlings Moderna, BioNTech are now on two different paths
25 Jul 2025 公告 Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
25 Jul 2025 公告 Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
25 Jul 2025 公告 Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union
21 Jul 2025 公告 BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
21 Jul 2025 公告 BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025
17 Jul 2025 公告 BioNTech Announces Ryan Richardson to Step Down from the Management Board
17 Jul 2025 公告 BioNTech Announces Ryan Richardson to Step Down from the Management Board
17 Jun 2025 CNBC Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
12 Jun 2025 公告 BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
12 Jun 2025 公告 BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
10 Jun 2025 CNBC RFK Jr.'s firing of CDC vaccine panel undermines science, could threaten public health, experts say
02 Jun 2025 公告 BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
02 Jun 2025 公告 BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
02 Jun 2025 公告 BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
显示更多
除息日 公告日期 支付日期 详情
02 Jun 2022 - 17 Jun 2022 2.111 现金

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2022 2.11 1 1.41

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票